1. American Academy of Child and Adolescent Psychiatrists. (2005). AACAP position statement on oversight of psychotropic medication use for children in state custody: A best principles guideline. Retrieved from https://www.aacap.org/App_Themes/AACAP/docs/clinical_practice_center/systems_of_care/FosterCare_BestPrinciples_FINAL.pdf
2. American Academy of Child and Adolescent Psychiatrists. (2015). Recommendations about the use of psychotropic medications for children and adolescents involved in child-serving systems. Retrieved from https://www.aacap.org/App_Themes/AACAP/docs/clinical_practice_center/systems_of_care/AACAP_Psychotropic_Medication_Recommendations_2015_FINAL.pdf.
3. Barnett, E. R., Trepman, A. Z., Fuson, H. A., Acquilano, S. C., McLaren, J. L., Woloshin, S., & Leyenaar, J. K. (2019). Deprescribing psychotropic medications in children: Results of a national qualitative study. BMJ Quality & Safety. https://doi.org/10.1136/bmjqs-2019-010033
4. Bellonci, C., Huefner, J. C., Griffith, A. K., Vogel-Rosen, G., Smith, G. L., & Preston, S. (2013). Concurrent reductions in psychotropic medication, assault, and physical restraint in two residential treatment programs for youth. Children and Youth Services Review, 35(10), 1773–1779. https://doi.org/10.1016/j.childyouth.2013.08.007
5. Burcu, M., Safer, D. J., & Zito, J. M. (2016). Antipsychotic prescribing for behavioral disorders in us youth: Physician specialty, insurance coverage, and complex regimens. Pharmacoepidemiology and Drug Safety, 25(1), 26–34. https://doi.org/10.1002/pds.3897